France: Provepharm attracts €120m in strategic funding from Tikehau Capital

Private French pharmaceutical company, Provepharm Life Solutions, has closed  €120m (US$142m) in funding from French alternative asset management and investment firm, Tikehau Capital. Tikehau joins the group’s pool of banking investors, including Société Générale, BNP Paribas, Banque Populaire Méditerranée, Crédit Agricole Alpes Provence and Bpifrance. The new debt facility strengthens Provepharm’s financial resources and enables…

You must be a HMI Subscriber to view this content.

Subscribe Now »